Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Pharmacological Preconditioning in CABG Surgery
NCT07841054Completed
- Sponsor
- Bursa City Hospital
- Start
- Dec 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in acute kidney injury (AKI) (2 arms), sponsored by Bursa City Hospital. Primary endpoint: Incidence of postoperative acute kidney injury at 72 hours. Started Dec 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07841054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841054.